Abeona Therapeutics Inc. (ABEO) stock
ABEONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/3039% below fair value
$2.42+0.13 (+5.68%)
Close on Nov 13, 2026Market cap $138.39MP/E –Yield –
Abeona Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Abeona Therapeutics's enterprise value was -$218.39K on Nov 11, 2026, against $78.30M a year earlier. Over the last 5 years it ranged from -$40.51M to $246.62M, with a median of $72.19M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$218.39K | -100.2% |
| 2025 | Dec 31, 2025 | $88.78M | -41.0% |
| 2024 | Dec 31, 2024 | $150.41M | +115.8% |
| 2023 | Dec 29, 2023 | $69.72M | +54468.0% |
| 2022 | Dec 30, 2022 | $127.76K | – |
| 2021 | Dec 31, 2021 | -$32.37M | -212.4% |
| 2020 | Dec 31, 2020 | $28.79M | -75.8% |
| 2019 | Dec 31, 2019 | $119.05M | -46.6% |
| 2018 | Dec 31, 2018 | $222.92M | -61.1% |
| 2017 | Dec 29, 2017 | $572.80M | +346.2% |
| 2016 | Dec 30, 2016 | $128.37M | +7338.4% |
| 2015 | Jan 30, 2015 | $1.73M | -8.6% |
| 2014 | Dec 31, 2014 | $1.89M | -64.9% |
| 2013 | Dec 31, 2013 | $5.37M | -3.2% |
| 2012 | Dec 31, 2012 | $5.55M | – |
See a number that looks wrong?